MARKS TEY PHARMACY LIMITED


Director	OSORIO RODRIGUEZ, Jose


Registered Address	89 London Road
	Marks Tey
	Colchester
	CO6 1EB


Registered Number	03679174 (England and Wales)

Balance Sheet as at
31 December 2025

	Notes	2025		2024
		£	£	£	£
Fixed assets
Tangible assets	3		5,608		5,688
			5,608		5,688
Current assets
Stocks	4	32,500		33,250
Debtors	5	617,367		513,883
Cash at bank and on hand		379,932		240,584
		1,029,799		787,717
Creditors amounts falling due within one year	6	(401,413)		(352,110)
Net current assets (liabilities)			628,386		435,607
Total assets less current liabilities			633,994		441,295
Net assets			633,994		441,295
Capital and reserves
Called up share capital			500		500
Share premium			19,800		19,800
Profit and loss account			613,694		420,995
Shareholders' funds			633,994		441,295

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 3 September 2026, and are signed on its behalf by:

OSORIO RODRIGUEZ, Jose
Director
Registered Company No. 03679174

MARKS TEY PHARMACY LIMITED

Notes to the Financial Statements
for the year ended 31 December 2025

1.	Accounting policies

	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

	Statement of compliance
	These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention

	Turnover policy
	Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

	Revenue from sale of goods
	Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

Revenue from sale of goods

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Employee benefits
	The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

	Foreign currency translation
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

Foreign currency translation

Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

	Tangible fixed assets and depreciation
	Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:


		Reducing balance (%)
	Office Equipment	25

	Finance leases and hire purchase contracts
	Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.

	Stocks and work in progress
	Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

2.	Average number of employees


		2025		2024
	Average number of employees during the year	12		13

3.	Tangible fixed assets

	Land & buildings	Plant & machinery	Fixtures & fittings	Office Equipment	Total
	£	£	£	£	£
Cost or valuation
At 01 January 25	114,930	29,118	107,872	12,645	264,565
Additions	-	-	-	2,124	2,124
At 31 December 25	114,930	29,118	107,872	14,769	266,689
Depreciation and impairment
At 01 January 25	114,930	29,118	107,872	6,957	258,877
Charge for year	-	-	-	2,204	2,204
At 31 December 25	114,930	29,118	107,872	9,161	261,081
Net book value
At 31 December 25	-	-	-	5,608	5,608
At 31 December 24	-	-	-	5,688	5,688

4.	Stocks

	2025	2024
	£	£
Finished goods	32,500	33,250
Total	32,500	33,250

5.	Debtors: amounts due within one year

	2025	2024
	£	£
Trade debtors / trade receivables	289,605	278,720
Amounts owed by group undertakings	290,577	199,676
Other debtors	31,645	30,401
Prepayments and accrued income	5,540	5,086
Total	617,367	513,883

6.	Creditors: amounts due within one year

	2025	2024
	£	£
Trade creditors / trade payables	189,484	175,039
Taxation and social security	72,239	47,158
Payments received on account	134,433	126,856
Other creditors	5,162	2,849
Accrued liabilities and deferred income	95	208
Total	401,413	352,110


	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

7.	Related party transactions
	At the yearend, the company was owed £290,577 (2024: £199,676) by Marks Tey Healthcare Ltd. The companies are related as Marks Tey Healthcare Ltd owns 100% share capital of Marks Tey Pharmacy Ltd.